Seagen
SGEN
#546
Rank
S$55.92 B
Marketcap
S$296.42
Share price
-0.07%
Change (1 day)
63.54%
Change (1 year)

Seagen (SGEN) - Cash on Hand

Cash on Hand as of September 2023 : S$1.60 Billion

According to Seagen 's latest financial reports the company has S$1.60 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Seagen - Cash on Hand chart (from 2001 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$2.32 B-20.35%
2021-12-31S$2.92 B-17.03%
2020-12-31S$3.51 B200.63%
2019-12-31S$1.17 B86.34%
2018-12-31S$0.62 B13.69%
2017-12-31S$0.55 B-38.31%
2016-12-31S$0.89 B-11.14%
2015-12-31S$1.00 B143.44%
2014-12-31S$0.41 B-12.67%
2013-12-31S$0.47 B6.45%
2012-12-31S$0.44 B4.01%
2011-12-31S$0.42 B17.98%
2010-12-31S$0.36 B-0.86%
2009-12-31S$0.36 B169%
2008-12-31S$0.13 B-15.06%
2007-12-31S$0.16 B26.54%
2006-12-31S$0.12 B79.09%
2005-12-31S$70.71 M16.72%
2004-12-31S$60.58 M-12.66%
2003-12-31S$69.37 M51.55%
2002-12-31S$45.77 M-41.01%
2001-12-31S$77.59 M84.02%
2000-12-31S$42.16 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ImmunoGen
IMGN
S$0.78 B-51.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$5.13 B 220.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.75 B-52.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S$72.74 M-95.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$19.41 B 1,111.33%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$5.75 B 259.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
S$7.34 B 358.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$21.38 B 1,234.04%๐Ÿ‡บ๐Ÿ‡ธ USA